Kinase inhibitors

Details Kinase inhibitors Kinase inhibitors

2007-08-10

2011-10-11

Anderson, Rebecca (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C548S517000

Reexamination Certificate

active

08034957

ABSTRACT:
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.

REFERENCES:
patent: 5792783 (1998-08-01), Tang et al.
patent: 5834504 (1998-11-01), Tang et al.
patent: 5883113 (1999-03-01), Tang et al.
patent: 5883116 (1999-03-01), Tang et al.
patent: 5886020 (1999-03-01), Tang et al.
patent: 6541504 (2003-04-01), Andrews et al.
patent: 6559173 (2003-05-01), Andrews et al.
patent: 6699863 (2004-03-01), Andrews et al.
patent: 6747025 (2004-06-01), Andrews et al.
patent: 6765012 (2004-07-01), Andrews et al.
patent: 7005444 (2006-02-01), Andrews et al.
patent: 7015220 (2006-03-01), Andrews et al.
patent: 7060844 (2006-06-01), Andrews et al.
patent: WO2006/052936 (2006-05-01), None
patent: WO 2007/008895 (2007-01-01), None
patent: WO2007/008985 (2007-01-01), None
Golub et al. Science (1999), vol. 286 531-537.
Lala et al. Cancer and Metastasis Reviews (1998), 17(1), 91-106.
Plowman et al, 1994, DN&P 7(6): 334-339.
Bolen, 1993, Oncogen 8: 2025-2031.

Affiliated with

Also associated with

Rating

Kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4292208